Bank of New York Mellon Corp - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$504,000
+0.2%
500,0000.0%0.00%
Q3 2021$503,000
+1.8%
500,0000.0%0.00%
Q2 2021$494,000
-4.6%
500,0000.0%0.00%
Q1 2021$518,000
-66.2%
500,000
-73.0%
0.00%
-100.0%
Q1 2020$1,532,000
-4.4%
1,850,0000.0%0.00%
Q4 2019$1,603,000
+3.8%
1,850,0000.0%0.00%
Q3 2019$1,544,000
-3.3%
1,850,0000.0%0.00%
Q2 2019$1,596,0001,850,0000.00%
Other shareholders

There were no reported owners of LIGAND PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of LIGAND PHARMACEUTICALS INC shareholders